Literature DB >> 26167513

Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment.

Fabián Vázquez-Santiago1, Yashira García1, Ivelisse Rivera-Román1, Richard J Noel2, Valerie Wojna3, Loyda M Meléndez4, Vanessa Rivera-Amill1.   

Abstract

OBJECTIVE: Combined antiretroviral treatment (cART) has changed the clinical presentation of HIV-associated neurocognitive disorders (HAND) to that of the milder forms of the disease. Asymptomatic neurocognitive impairment (ANI) is now more prevalent and is associated with increased morbidity and mortality risk in HIV-1-infected people. HIV-1 envelope (env) genetic heterogeneity has been detected within the central nervous system (CNS) of individuals with ANI. Changes within env determine co-receptor use, cellular tropism, and neuropathogenesis. We hypothesize that compartmental changes are associated with HIV-1 env C2V4 during ANI and sought to analyze paired HIV-1 env sequences from plasma and cerebrospinal fluid (CSF) of a female subject undergoing long-term cART.
METHODS: Paired plasma and CSF samples were collected at 12-month intervals and HIV-1 env C2V4 was cloned and sequenced.
RESULTS: Phylogenetic analysis of paired samples consistently showed genetic variants unique to the CSF. Phenotypic prediction showed CCR5 (R5) variants for all CSF-derived sequences and showed minor X4 variants (or dual-tropic) in the plasma at later time points. Viral compartmentalization was evident throughout the study, suggesting that the occurrence of distinctive env strains may contribute to the neuropathogenesis of HAND.
CONCLUSIONS: Our study provides new insights about the genetic characteristics within the C2V4 of HIV-1 env that persist after long-term cART and during the course of persistent ANI.

Entities:  

Keywords:  HAND; HIV; asymptomatic neurocognitive impairment; cerebrospinal fluid; envelope; evolution; plasma

Year:  2015        PMID: 26167513      PMCID: PMC4498488          DOI: 10.4172/2324-8955.1000135

Source DB:  PubMed          Journal:  J Virol Antivir Res        ISSN: 2324-8955


  64 in total

Review 1.  HIV-1 fitness and macrophages.

Authors:  Maureen M Goodenow; Stephanie L Rose; Daniel L Tuttle; John W Sleasman
Journal:  J Leukoc Biol       Date:  2003-08-21       Impact factor: 4.962

2.  Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants.

Authors:  T K Smit; B Wang; T Ng; R Osborne; B Brew; N K Saksena
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

3.  Regulation of chemokine receptor expression in human microglia and astrocytes.

Authors:  Geraldine Flynn; Seema Maru; Jane Loughlin; Ignacio A Romero; David Male
Journal:  J Neuroimmunol       Date:  2003-03       Impact factor: 3.478

4.  Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.

Authors:  Q Hu; J O Trent; G D Tomaras; Z Wang; J L Murray; S M Conolly; J M Navenot; A P Barry; M L Greenberg; S C Peiper
Journal:  J Mol Biol       Date:  2000-09-15       Impact factor: 5.469

5.  Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia.

Authors:  P van der Meer; A M Ulrich; F Gonźalez-Scarano; E Lavi
Journal:  Exp Mol Pathol       Date:  2000-12       Impact factor: 3.362

6.  Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

Authors:  P R Gorry; G Bristol; J A Zack; K Ritola; R Swanstrom; C J Birch; J E Bell; N Bannert; K Crawford; H Wang; D Schols; E De Clercq; K Kunstman; S M Wolinsky; D Gabuzda
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

Authors:  Paul R Gorry; Joann Taylor; Geoffrey H Holm; Andrew Mehle; Tom Morgan; Mark Cayabyab; Michael Farzan; Hui Wang; Jeanne E Bell; Kevin Kunstman; John P Moore; Steven M Wolinsky; Dana Gabuzda
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

Authors:  Ming Zhang; Brian Gaschen; Wendy Blay; Brian Foley; Nancy Haigwood; Carla Kuiken; Bette Korber
Journal:  Glycobiology       Date:  2004-06-02       Impact factor: 4.313

9.  HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain.

Authors:  Guido Van Marle; Sean B Rourke; Kunyan Zhang; Claudia Silva; Julie Ethier; M John Gill; Christopher Power
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

10.  Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.

Authors:  Mark A Jensen; Fu-Sheng Li; Angélique B van 't Wout; David C Nickle; Daniel Shriner; Hong-Xia He; Sherry McLaughlin; Raj Shankarappa; Joseph B Margolick; James I Mullins
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more
  6 in total

1.  HIV gp120 sequence variability associated with HAND in Hispanic Women.

Authors:  Krystal Colón; Fabián Vázquez-Santiago; Vanessa Rivera-Amill; Gisela Delgado; Steven E Massey; Valerie Wojna; Richard J Noel; Loyda M Meléndez
Journal:  J Virol Antivir Res       Date:  2015-10-06

2.  Genetic analyses of HIV env associated with uveitis in antiretroviral-naive individuals.

Authors:  Corey A Williams-Wietzikoski; Isaac D So; Marta E Bull; Tanawan Samleerat; Kessara Pathanapitoon; Paradee Kunavisarut; Natedao Kongyai; Nicole Ngo-Giang-Huong; Lisa M Frenkel; Wasna Sirirungsi
Journal:  AIDS       Date:  2017-08-24       Impact factor: 4.177

3.  Envelope gene evolution and HIV-1 neuropathogenesis.

Authors:  Fabián J Vázquez-Santiago; Vanessa Rivera-Amill
Journal:  J Neuroinfect Dis       Date:  2015-08-20

Review 4.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.

Authors:  Thomas M Gates; Lucette A Cysique
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

5.  A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques.

Authors:  Kenta Matsuda; Nadeene E Riddick; Cheri A Lee; Sarah B Puryear; Fan Wu; Bernard A P Lafont; Sonya Whitted; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2017-08-07       Impact factor: 6.823

6.  HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana.

Authors:  Nametso Kelentse; Sikhulile Moyo; Mompati L Mogwele; Doreen Ditshwanelo; Baitshepi Mokaleng; Natasha O Moraka; Kwana Lechiile; Tshepo B Leeme; David S Lawrence; Rosemary Musonda; Ishmael Kasvosve; Thomas S Harrison; Joseph N Jarvis; Simani Gaseitsiwe
Journal:  Viruses       Date:  2020-12-07       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.